A lung CT of a COVID-19 patient, showing ground-glass opacities in the lung from COVID pneumonia. Image courtesy of John Kim.
July 9, 2020 — With increased lung CT exam paradigms being used in the current COVID-19 (SARS-CoV-2) outbreak, and an increase in lung nodules and incidental findings to be monitored for years, PenRad Technologies Inc. has decided to donate PenLung, its web-based lung CT tracking software ecosystem to U.S. diagnostic imaging centers. PenRad structured reporting allows for easy access to all patients with a diagnosis of COVID-19, incidental findings on lung CT exams and digital chest X-rays and facilitates long term follow-up of both.
"In light of the current COVID-19 pandemic and based on some of the early literature focused on lung abnormalities demonstrated on CT exams brought about by the disease, we have updated our software to track key information in the patients likely long term journey, specific to COVID-19,” said Greg Gustafson, PenRad founder and CEO. “In light of the current pressures in diagnostic imaging and what’s sure to be an oncoming increase in procedure volume, we have decided to provide this software platform to diagnostic imaging centers at no charge through 2020.”
PenRad’s secure, web-based software ecosystem is secure and easily accessible by diagnostic imaging centers, the platform streamlines the overall patient experience and offloads a significant portion of the work typically performed by technologists allowing them more time to focus on patients and patient throughput.
"In this time of need as our front-line healthcare providers are looking for ways to streamline their typical workflow, stay safe and ease patient anxiety, PenRad is helping with removing the time-consuming burden of long-term tracking of patient data, freeing technologists to work with patients,” Gustafson said. “Keeping track of patient data, including lung nodules, structural changes and incidental findings, alone generates additional burden and liability for imaging facilities and radiologists. Add to this, a likely significant increase in lung computed tomography (CT) exams, and programs can quickly become overburdened. We are here to do our part to help in the follow-up of COVID-19 lung disease and incidental findings.”
Diagnostic imaging centers should contact PenRad today, and we will set up a facility account instantly on our Web server and get your team started with PenLung. All fees waived until Dece. 31, 2020.
PenRad offers solutions for breast imaging and PenLung, LDCT lung screening (updated to included COVID-19 induced findings) to enhance practice workflow. Designed for flexibility and easy integration PenRad’s client/server SQL enterprise architecture supports all customers ranging from individual imaging facilities to enterprise systems, while maintaining individual statistics, workflow and automation needs for each facility.
For more information: www.penrad.com
September 01, 2026 
